Why was Qantas customer data leaked online?
How are China’s rare earth curbs impacting trade?
What caused the $19B crypto market liquidation?
Why did Trump threaten 100% tariffs on China?
How is AI transforming top tech company valuations?
Why are federal workers facing layoffs amid shutdown?
What impact will Lowe’s latest acquisition have?
Bristol Myers Squibb Strengthens and Diversifies Cell Therapy Portfolio with Acquisition of Orbital Therapeutics
news.bms.com/news/details/2025/Bristol-Myers-Squibb-Strengthens-and-Diversifies-Cell-Therapy-Portfolio-with-Acquisition-of-Orbital-Therapeutics/default.aspx
Acquisition includes OTX-201, an investigational next-generation CAR T-cell therapy designed to reprogram cells in vivo with potential best-in-class profile for autoimmune diseases
Transaction further strengthens BMS’s industry-leading cell therapy portfolio, expanding CAR T-cell access…
This story appeared on news.bms.com, 2025-10-10 16:26:11.497000.